Clinical Trial Update: DIA:CONN P8(Smart Insulin Pen) Study in Diabetes Patients [NA]

View source ↗

Summary

A completed clinical trial update for the DIA:CONN P8 Smart Insulin Pen in insulin-requiring diabetes, including Type 1, Type 2, and pancreatogenic diabetes mel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatogenic Diabetes Mellitus
• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• DIA:CONN P8 Smart Insulin Pen

Snippet

Sponsor: G2e Co., Ltd | Conditions: Diabetes (Insulin-requiring, Type 1 or Type 2), Pancreatogenic Diabetes Mellitus | NA | Status: COMPLETED